Next Article in Journal
The ORF1ab of Feline Coronavirus Plays a Critical Role in Regulating the Innate Immune Response
Previous Article in Journal
Ruvidar®—An Effective Anti-Herpes Simplex Virus Agent
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233

by
Renan Galuzo
1,†,
Thiago Lazari Machado
1,†,
Ryann de Souza Nascimento
1,†,
Jorvan Ramos de Medeiros
1,
Luciana Neves Tubarão
1,
Jane Silva
1,
Vanessa Pimenta Rocha
1,
Tamiris Azamor
1,
Felipe Soares Coelho
1,
Andrea Marques Vieira da Silva
1,
Lorenna Carvalho da Rosa
1,
Juliana Fernandes Amorim da Silva
1,
Renata Tourinho Santos
1,
Rodrigo Müller
1,
Carolina Baeta Salvador Várady
1,
Ana Paula Dinis Ano Bom
1,
Patricia Cristina da Costa Neves
1,2,† and
Juliana Gil Melgaço
1,*,†
1
Instituto de Tecnologia em Imunobiológicos, Bio-Manguinhos, Fundação Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-900, Brazil
2
Biological Sciences Building, Kensington Campus, University of New South Wales, Sydney, NSW 2033, Australia
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Viruses 2025, 17(9), 1281; https://doi.org/10.3390/v17091281
Submission received: 15 September 2025 / Accepted: 17 September 2025 / Published: 22 September 2025

Missing Institutional Review Board Statement

In the original publication [1], the Institutional Review Board Statement (IRBS) was not included in the Back Matter section in the standard format required by the journal. All experiments in the study were conducted in full compliance with the relevant ethical standards, and the corresponding ethics approvals were obtained prior to the study. The corrected statement is provided below.
The statement has now been added as follows:
  • Institutional Review Board Statement: The animal study protocol was approved by the Institutional Review Board (or Ethics Committee) of Fundação Oswaldo Cruz (protocol code P-6/20.3 (LW-17/20) on 6 July 2020 and renewed by protocol code 06/2024-3 (LBM-7/24) on 8 October 2024) by Bio-Manguinhos/Fundação Oswaldo Cruz. The protocol for the use of human samples was approved by the Institutional Review Board of Fundação Oswaldo Cruz (protocol code 34728920.4.0000.5262) on 3 November 2020.
The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Reference

  1. Galuzo, R.; Lazari Machado, T.; de Souza Nascimento, R.; Ramos de Medeiros, J.; Neves Tubarão, L.; Silva, J.; Pimenta Rocha, V.; Azamor, T.; Soares Coelho, F.; da Silva, A.M.V.; et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Galuzo, R.; Lazari Machado, T.; de Souza Nascimento, R.; Ramos de Medeiros, J.; Neves Tubarão, L.; Silva, J.; Pimenta Rocha, V.; Azamor, T.; Soares Coelho, F.; da Silva, A.M.V.; et al. Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233. Viruses 2025, 17, 1281. https://doi.org/10.3390/v17091281

AMA Style

Galuzo R, Lazari Machado T, de Souza Nascimento R, Ramos de Medeiros J, Neves Tubarão L, Silva J, Pimenta Rocha V, Azamor T, Soares Coelho F, da Silva AMV, et al. Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233. Viruses. 2025; 17(9):1281. https://doi.org/10.3390/v17091281

Chicago/Turabian Style

Galuzo, Renan, Thiago Lazari Machado, Ryann de Souza Nascimento, Jorvan Ramos de Medeiros, Luciana Neves Tubarão, Jane Silva, Vanessa Pimenta Rocha, Tamiris Azamor, Felipe Soares Coelho, Andrea Marques Vieira da Silva, and et al. 2025. "Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233" Viruses 17, no. 9: 1281. https://doi.org/10.3390/v17091281

APA Style

Galuzo, R., Lazari Machado, T., de Souza Nascimento, R., Ramos de Medeiros, J., Neves Tubarão, L., Silva, J., Pimenta Rocha, V., Azamor, T., Soares Coelho, F., da Silva, A. M. V., Carvalho da Rosa, L., da Silva, J. F. A., Santos, R. T., Müller, R., Várady, C. B. S., Ano Bom, A. P. D., Neves, P. C. d. C., & Melgaço, J. G. (2025). Correction: Galuzo et al. CLEC5A Activation in Inflammatory Monocytes: A Mechanism for Enhanced Adaptive Immunity Following COVID-19 mRNA Vaccination in a Preclinical Study. Viruses 2025, 17, 1233. Viruses, 17(9), 1281. https://doi.org/10.3390/v17091281

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop